Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April Heightened awareness generating interest from leading health ...

The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April ...

Shares of electronics manufacturing services company Sanmina (NASDAQ:SANM) jumped 5.4% in the afternoon session after ...

Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansionHINGHAM, ...

Microbot Medical has secured FDA authorization to move forward with the first human clinical trial of its LIBERTY Endovascular Robotic Surgical System, a disposable device designed to navigate ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics ...

Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S.The Company now has ...

The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of ...

HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement ...